Rodney A. White
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rodney A. White has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
Irwin Walot
12 shared publicationsGeorge Kopchok
10 shared publications- George E. Kopchok
Harbor-UCLA Medical Ctr. (United States)
8 shared publications Carlos Donayre
Division of Vascular Surgery, Harbor-UCLA Medical Center, Torrance, CA, USA
7 shared publications- Carlos E. Donayre
Harbor/UCLA Medical Center, Torrance, Calif 90502, USA
6 shared publications Carlos E. Donayre
Division of Vascular, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Harbor UCLA Medical Center, Torrance, Calif
5 shared publications
Latest Publications
- 1 August 2018
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 51, 270
In Vivo Assessment of Ascending & Arch Aortic Compliance
- 1 August 2018
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 51, 270
In Vivo Assessment of Ascending & Arch Aortic Compliance
- 14 October 2015
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 115 (eLetters)
An Alternative Anesthetic Technique on Nonagenerians Undergoing Endovascular Aortic Surgery and Long Term Outcomes
- 14 October 2015
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 115 (eLetters)
An Alternative Anesthetic Technique on Nonagenerians Undergoing Endovascular Aortic Surgery and Long Term Outcomes
- 1 June 2015
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 61 (6) , 105S
Pullout Forces for Modular Components of Physician-Modified Thoracoabdominal Aortic Endografts
- 1 June 2015
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 61 (6) , 105S
Pullout Forces for Modular Components of Physician-Modified Thoracoabdominal Aortic Endografts
- 1 March 2013
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 57 (3) , 832-833
Advisory statement on clinical use of modified aortic endografts from the Society for Vascular Surgery®
- 1 March 2013
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 57 (3) , 832-833
Advisory statement on clinical use of modified aortic endografts from the Society for Vascular Surgery®
- 30 September 2012
- Published by Elsevier in Seminars in Vascular Surgery
- Vol. 25 (3) , 144-152
Intravascular Ultrasound
- 30 September 2012
- Published by Elsevier in Seminars in Vascular Surgery
- Vol. 25 (3) , 144-152
Intravascular Ultrasound
- 30 August 2012
- Published by Wiley
- p. 112-124
Intravascular Ultrasound Imaging
- Open Access
- 7 August 2012
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 10 (1) , 159
Effects of sildenafil and/or muscle derived stem cells on myocardial infarction
Background: Previous studies have shown that long-term oral daily PDE 5 inhibitors (PDE5i) counteract fibrosis, cell loss, and the resulting dysfunction in tissues of various rat organs and that implantation of skeletal muscle-derived stem cells (MDSC) exerts some of these effects. PDE5i and stem cells in combination were found to be more effective in non-MI cardiac repair than each treatment separately. We have now investigated whether sildenafil at lower doses and MDSC, alone or in combination are effective to attenuate LV remodeling after MI in rats.Methods: MI was induced in rats by ligature of the left anterior descending coronary artery. Treatment groups were: “Series A”: 1) untreated; 2) oral sildenafil 3 mg/kg/day from day 1; and “Series B”: intracardiac injection at day 7 of: 3) saline; 4) rat MDSC (106cells); 5) as #4, with sildenafil as in #2. Before surgery, and at 1 and 4 weeks, the left ventricle ejection fraction(LVEF)was measured. LV sections were stained for collagen,myofibroblasts, apoptosis, cardiomyocytes, and iNOS, followed by quantitative image analysis.Western blots estimated angiogenesis and myofibroblast accumulation, as well as potential sildenafil tachyphylaxis by PDE 5 expression. Zymography estimated MMPs 2 and 9 in serum.Results: As compared to untreated MI rats, sildenafil improved LVEF, reduced collagen, myofibroblasts, and circulating MMPs, and increased cardiac troponin T. MDSC replicated most of these effects and stimulated cardiac angiogenesis. Concurrent MDSC/sildenafil counteracted cardiomyocyte and endothelial cells loss, but did not improve LVEF or angiogenesis, and upregulated PDE 5.Conclusions: Long-term oral sildenafil, or MDSC given separately, reduce the MI fibrotic scar and improve left ventricular function in this rat model. The failure of the treatment combination may be due to inducing overexpression of PDE5.
- 7 August 2012
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 10 (1) , 159
Open AccessEffects of sildenafil and/or muscle derived stem cells on myocardial infarction
Background: Previous studies have shown that long-term oral daily PDE 5 inhibitors (PDE5i) counteract fibrosis, cell loss, and the resulting dysfunction in tissues of various rat organs and that implantation of skeletal muscle-derived stem cells (MDSC) exerts some of these effects. PDE5i and stem cells in combination were found to be more effective in non-MI cardiac repair than each treatment separately. We have now investigated whether sildenafil at lower doses and MDSC, alone or in combination are effective to attenuate LV remodeling after MI in rats.Methods: MI was induced in rats by ligature of the left anterior descending coronary artery. Treatment groups were: “Series A”: 1) untreated; 2) oral sildenafil 3 mg/kg/day from day 1; and “Series B”: intracardiac injection at day 7 of: 3) saline; 4) rat MDSC (106cells); 5) as #4, with sildenafil as in #2. Before surgery, and at 1 and 4 weeks, the left ventricle ejection fraction(LVEF)was measured. LV sections were stained for collagen,myofibroblasts, apoptosis, cardiomyocytes, and iNOS, followed by quantitative image analysis.Western blots estimated angiogenesis and myofibroblast accumulation, as well as potential sildenafil tachyphylaxis by PDE 5 expression. Zymography estimated MMPs 2 and 9 in serum.Results: As compared to untreated MI rats, sildenafil improved LVEF, reduced collagen, myofibroblasts, and circulating MMPs, and increased cardiac troponin T. MDSC replicated most of these effects and stimulated cardiac angiogenesis. Concurrent MDSC/sildenafil counteracted cardiomyocyte and endothelial cells loss, but did not improve LVEF or angiogenesis, and upregulated PDE 5.Conclusions: Long-term oral sildenafil, or MDSC given separately, reduce the MI fibrotic scar and improve left ventricular function in this rat model. The failure of the treatment combination may be due to inducing overexpression of PDE5.
- 1 August 2012
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 56 (2) , 579
Determinants of Abdominal Aortic Aneurysm Sac Enlargement After Endovascular Aneurysm Repair with a Long-Term Follow-Up to 15 Years
- 1 August 2012
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 56 (2) , 579
Determinants of Abdominal Aortic Aneurysm Sac Enlargement After Endovascular Aneurysm Repair with a Long-Term Follow-Up to 15 Years
- 1 June 2010
- Published by SAGE Publications in Perspectives in Vascular Surgery and Endovascular Therapy
- Vol. 22 (2) , 137-138
Commentary on "Carotid Endarterectomy or Carotid Stenting? Matching the Patient to the Intervention"
- 1 June 2010
- Published by SAGE Publications in Perspectives in Vascular Surgery and Endovascular Therapy
- Vol. 22 (2) , 137-138
Commentary on "Carotid Endarterectomy or Carotid Stenting? Matching the Patient to the Intervention"
- 1 June 2007
- Published by SAGE Publications in Perspectives in Vascular Surgery and Endovascular Therapy
- Vol. 19 (2) , 193
Commentary on "Endovascular Repair of the Aortic Arch"
- 1 June 2007
- Published by SAGE Publications in Perspectives in Vascular Surgery and Endovascular Therapy
- Vol. 19 (2) , 193
Commentary on "Endovascular Repair of the Aortic Arch"